martes, 24 de diciembre de 2024

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-once-daily-glp-1-injection-lower-blood-sugar-patients-type-2-diabetes?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario